Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
2020 · Cancer Discovery · 840 citations
https://doi.org/10.1158/2159-8290.cd-19-1384
G
Géraldine Gentric
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
2.8K
Citations
17
h-index
17
i10-index
Géraldine Gentric is an academic researcher from Inserm. The author has contributed to research in topics: Ethics in Clinical Research & Health Systems, Economic Evaluations, Quality of Life & Immune cells in cancer. The author has an h-index of 17, co-authored 47 publications.
ORCID: 0000-0002-7558-8705Papers by this author
worksPML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
2018 · Cell Metabolism · 296 citations
https://doi.org/10.1016/j.cmet.2018.09.002
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
2018 · Nature Communications · 272 citations
https://doi.org/10.1038/s41467-018-03348-z
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
2024 · Nature Communications · 115 citations
https://doi.org/10.1038/s41467-024-47068-z
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
2024 · Nature Communications · 40 citations
https://doi.org/10.1038/s41467-024-45595-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat